📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Galectin-3, a novel endogenous TREM2 ligand, detrimentally regulates inflammatory response in Alzheimer's disease. (2019)

First Author: Boza-Serrano A

Attributed to: Microglial phagocytic receptors P2Y6 & VNR in brain pathology and therapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1007/s00401-019-02013-z

PubMed Identifier: 31006066

Publication URI: http://europepmc.org/abstract/MED/31006066

Type: Journal Article/Review

Volume: 138

Parent Publication: Acta neuropathologica

Issue: 2

ISSN: 0001-6322